GCA Therapeutics Ltd

Corporate Overview

GCA Therapeutics Ltd (GCAT) is a US based, specialty pharmaceutical company focusing on in-licensing, acquisition and marketing of mid through late stage drug candidates and technologies from North America and the EU. GCAT applies its expertise and resources in pre-clinical, clinical, and final regulatory review and approval phases to commercialize products for use in the Chinese market. GCAT has been currently in discussion with several US and European biotech and pharma firms to bring several drugs and devices to market through its joint ventures in China. Initially, GCAT will market its products through a 3rd party distribution partnership and will construct or acquire manufacture capabilities in China at a later date.

Designed and Developed by Golden Dog